Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,329 | -99,073 | -40,414 | -12,203 | -18,099 |
| Depreciation Amortization | 1,203 | 902 | 888 | 235 | 22 |
| Accounts payable and accrued liabilities | -12,226 | 13,574 | 2,664 | -213 | -2,177 |
| Other Working Capital | -16,445 | 18,951 | 3,577 | -5,546 | -3,525 |
| Other Operating Activity | -838 | -7,421 | 5,507 | 555 | 6,654 |
| Operating Cash Flow | $-73,635 | $-73,067 | $-27,778 | $-17,172 | $-17,125 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,576 | 21,578 | -23,338 | 0 | 5,818 |
| PPE Investments | -207 | -1,346 | -22 | -4 | -7 |
| Other Investing Activity | 0 | 0 | 0 | 40 | 30 |
| Investing Cash Flow | $-3,783 | $20,232 | $-23,360 | $36 | $5,841 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 24,700 | -210 | 13,303 | 12,200 |
| Common Stock Issued | 35,761 | 54,608 | 87,740 | -259 | 68 |
| Other Financing Activity | -4,505 | -879 | 0 | 0 | 6,758 |
| Financing Cash Flow | $31,256 | $78,429 | $87,530 | $13,044 | $19,026 |
| Exchange Rate Effect | -31 | 0 | -165 | 0 | N/A |
| Beginning Cash Position | 65,624 | 40,030 | 3,803 | 7,895 | 153 |
| End Cash Position | 19,431 | 65,624 | 40,030 | 3,803 | 7,895 |
| Net Cash Flow | $-46,193 | $25,594 | $36,227 | $-4,092 | $7,742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,635 | -73,067 | -27,778 | -17,172 | -17,125 |
| Capital Expenditure | -207 | -1,346 | -22 | -4 | -7 |
| Free Cash Flow | -73,842 | -74,413 | -27,800 | -17,176 | -17,132 |